SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Alamar Biosciences appoints Robert Ragusa to board

Alamar Biosciences named Robert Ragusa a Class I director effective September 1, 2026, and added him to its audit, compensation and nominating and corporate governance committees.

ALMR
SquawkNews Desk

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories

UK CMA Finds AkzoNobel-Axalta Merger May Substantially Lessen Competition The UK Competition and Markets Authority decided the proposed merger may be expected to substantially lessen competition in one or more UK markets. M impact | REGULATION | Nov 11, 2026, 07:55 AM UTC UK CMA Threatens Phase 2 Probe of Unilever-McCormick Deal The CMA said it would launch an in-depth Phase 2 probe unless the companies submit undertakings addressing its concerns by 18 November. M impact | REGULATION | Nov 11, 2026, 07:49 AM UTC UK CMA Says McCormick-Unilever Deal May Substantially Reduce Competition The UK Competition and Markets Authority said the deal may result in a substantial lessening of competition. M impact | REGULATION | Nov 11, 2026, 07:36 AM UTC Russia Places Japan Tobacco Entities Under Temporary Administration M impact | REGULATION | Nov 11, 2026, 07:28 AM UTC UK CMA Says McCormick–Unilever Deal May Substantially Lessen Competition The UK Competition and Markets Authority said the deal may be expected to result in a substantial lessening of competition. M impact | REGULATION | Nov 11, 2026, 07:22 AM UTC South Korea Fines 15 Firms $1.2 Billion for Bond Auction Collusion The Korea Fair Trade Commission imposed total fines of 1.627 trillion won on five banks and 10 brokerage firms for colluding in government bond auctions. M impact | REGULATION | Nov 11, 2026, 07:05 AM UTC